在小细胞肺癌中,LDH-H3K18La-Nur77轴增强免疫逃生
Xiaoling Shang1, Bo Cheng2, Chenyue Zhang3
1Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250017, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|June 24, 2025
概括
乳酸驱动小细胞肺癌 (SCLC) 的免疫逃脱通过基因素乳化,损害T细胞的反应. 向乳酸代谢可以提高免疫治疗对SCLC的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 代谢过程中的代谢.
背景情况:
- 小细胞肺癌 (SCLC) 具有显著的治疗挑战,免疫疗法反应有限.
- 在SCLC中,免疫逃生机制导致患者的治疗结果不佳.
研究的目的:
- 为了确定新的表观遗传机制驱动免疫逃脱在SCLC.
- 研究乳酸代谢在调节SCLC抗瘤免疫力中的作用.
- 探索乳酸代谢作为治疗目标,以增强SCLC免疫疗法.
主要方法:
- 对SCLC患者队列的多个omics分析 (代谢学,TCR测序) (Shanzhong和IMpower133).
- 染色体免疫沉-定量聚合酶连锁反应 (ChIP-qPCR) 和 luciferase 记者测定.
- 临床前SCLC模型评估乳酸抑制对T细胞功能和免疫治疗疗效的影响.
主要成果:
- 乳酸脱酶 (LDH) 水平升高与SCLC患者免疫治疗结果较差相关.
- 在H3K18La的乳酸诱导的组分激素乳化促进了Nur77在CD8+T细胞中的表达,导致T细胞功能受损.
- 在临床前模型中准乳酸代谢恢复了T细胞活性,改善了PD-1阻断的有效性,减少了瘤负担并增加了生存率.
结论:
- 乳酸诱导的组素乳酸化是一种新型的SCLC免疫逃避机制.
- 在LDH-H3K18La-Nur77轴调节SCLC的免疫反应.
- 向乳酸代谢是克服SCLC免疫疗法耐药性的有希望的策略.
更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.1K
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
4.3K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K